BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 19031164)

  • 1. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy.
    Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Onimaru R; van den Heuvel MM; Belderbos J; Lebesque JV; Sonke JJ
    Radiother Oncol; 2009 Jun; 91(3):307-13. PubMed ID: 19321217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
    Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.
    Levegrün S; Hof H; Essig M; Schlegel W; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):796-808. PubMed ID: 15183483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of patient characteristics for the prediction of radiation-induced lung toxicity.
    Dehing-Oberije C; De Ruysscher D; van Baardwijk A; Yu S; Rao B; Lambin P
    Radiother Oncol; 2009 Jun; 91(3):421-6. PubMed ID: 19147245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
    Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
    McCammon R; Schefter TE; Gaspar LE; Zaemisch R; Gravdahl D; Kavanagh B
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):112-8. PubMed ID: 18786780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer.
    Kyas I; Hof H; Debus J; Schlegel W; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):768-74. PubMed ID: 17097829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
    Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
    Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
    Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.
    Belderbos J; Heemsbergen W; Hoogeman M; Pengel K; Rossi M; Lebesque J
    Radiother Oncol; 2005 May; 75(2):157-64. PubMed ID: 15890421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
    Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric and clinical predictors for radiation-induced esophageal injury.
    Ahn SJ; Kahn D; Zhou S; Yu X; Hollis D; Shafman TD; Marks LB
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):335-47. PubMed ID: 15667951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    Koh ES; Sun A; Tran TH; Tsang R; Pintilie M; Hodgson DC; Wells W; Heaton R; Gospodarowicz MK
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):223-8. PubMed ID: 16904523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.